The Biology and Genetics of SEDC
At a Glance
Spondyloepiphyseal Dysplasia Congenita (SEDC) is caused by a mutation in the COL2A1 gene, which disrupts the production of Type II collagen. This affects cartilage development, leading to skeletal changes like flattened vertebrae (platyspondyly) and potential impacts on vision and hearing.
To understand Spondyloepiphyseal Dysplasia Congenita (SEDC), it helps to look at the very “building blocks” of the body. The condition is not just a collection of random symptoms; rather, it is the result of a specific change in how the body produces a vital structural protein called Type II collagen [1].
The Role of the COL2A1 Gene
Every person has two copies of the COL2A1 gene. This gene acts like a blueprint or a set of instructions for making Type II collagen [2]. In individuals with SEDC, one copy of this gene contains a mutation—a “typo” in the instructions—that leads to the production of collagen that is either misshapen or insufficient [3][4].
Think of collagen as the “glue” or the rebar in a building’s concrete. Type II collagen is specifically used to create hyaline cartilage, a smooth, slippery tissue that covers the ends of bones and forms the structure of several key body parts [1]. Because this “glue” is not working correctly, the tissues that rely on it cannot develop or function normally [5].
Why SEDC Affects More Than Just Height
Because Type II collagen is found in specific areas throughout the body, the effects of a COL2A1 mutation are widespread:
- The Spine: It is a major component of the intervertebral discs (the cushions between your spinal bones) [1].
- The Eyes: It provides the structure for the vitreous humor, the clear, gel-like substance that fills the eye and keeps the retina in place [1][6].
- The Ears: It is found in the cartilage of the inner ear and the tiny bones (ossicles) that help us hear [1][7].
- The Joints: It forms the smooth surface at the ends of all long bones, allowing for fluid movement [1].
Understanding Clinical Terms
When you read medical or radiology reports, you will likely encounter two specific terms that describe how SEDC affects the skeleton:
Platyspondyly (Flattened Vertebrae)
Platyspondyly comes from the Greek words for “flat” and “vertebrae” [2]. In SEDC, the bones of the spine do not grow to their full height. Instead of being rectangular blocks, they appear flattened or squashed on an X-ray [8]. This flattening is the primary reason individuals with SEDC have a “short trunk” or a shorter torso [2].
Epiphyseal Abnormalities
The epiphysis is the rounded end of a long bone (like the thigh bone) where growth occurs. In SEDC, these ends do not develop properly or may be delayed in appearing on X-rays [2]. This can lead to joints that are shaped differently, which may affect mobility or cause joints to wear down more quickly over time [9].
How SEDC is Inherited
SEDC is an autosomal dominant condition [2]. This means that only one mutated copy of the COL2A1 gene is needed to cause the condition [1].
In the vast majority of cases, the mutation is de novo, meaning it occurred spontaneously for the first time during conception and was not passed down by either parent [10][4]. If a mutation is de novo, the parents have a very low risk of having another child with SEDC (the risk is not strictly zero due to a rare phenomenon called germline mosaicism). However, the individual with SEDC will have a 50% chance of passing the gene on to each of their own future children [11]. Genetic counseling can help you understand these risks and the specific details of genetic test results [12].
Common questions in this guide
What gene causes SEDC?
Is SEDC inherited from a parent?
What does platyspondyly mean on an X-ray report?
Why does SEDC affect vision and hearing?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does this 'de novo' mutation mean my future children or my child's future children will inherit it?
- 2.Can you show me the 'platyspondyly' on the X-rays and explain how it affects growth?
- 3.Based on this specific COL2A1 mutation, are there any known patterns or related symptoms we should be more watchful for?
- 4.Are there any research studies or clinical trials currently investigating therapies for COL2A1 mutations?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
COL2A1 Gene Mutations: Mechanisms of Spondyloepiphyseal Dysplasia Congenita.
Nenna R, Turchetti A, Mastrogiorgio G, Midulla F
The application of clinical genetics 2019; (12()):235-238 doi:10.2147/TACG.S197205.
PMID: 31824186 - 2
A novel COL2A1 mutation causing spondyloepiphyseal dysplasia congenita in a Chinese family.
Zhou T, Yang X, Chen Z, et al.
Journal of clinical laboratory analysis 2021; (35(4)):e23728 doi:10.1002/jcla.23728.
PMID: 33590889 - 3
A Heterozygous Mutation in the Triple Helical Region of the Alpha 1 (II) Chain of the COL2A1 Protein Causes Non-Lethal Spondyloepiphyseal Dysplasia Congenita.
Almatrafi A, Alfadhli F, Khan YN, et al.
Genetic testing and molecular biomarkers 2019; (23(5)):310-315 doi:10.1089/gtmb.2018.0301.
PMID: 30932712 - 4
A novel de novo mutation in COL2A1 leading to spondyloepiphyseal dysplasia congenita in a Chinese family.
Xiong Q, Liu Y, Xue Y, et al.
Human genome variation 2018; (5()):17059 doi:10.1038/hgv.2017.59.
PMID: 29354277 - 5
Skeletal deterioration in COL2A1-related spondyloepiphyseal dysplasia occurs prior to osteoarthritis.
Rolvien T, Yorgan TA, Kornak U, et al.
Osteoarthritis and cartilage 2020; (28(3)):334-343 doi:10.1016/j.joca.2019.12.011.
PMID: 31958497 - 6
Novel COL2A1 variants in Japanese patients with spondyloepiphyseal dysplasia congenita.
Akahira-Azuma M, Enomoto Y, Nakamura N, et al.
Human genome variation 2022; (9(1)):16 doi:10.1038/s41439-022-00193-x.
PMID: 35581182 - 7
Discovery of sensorineural hearing loss and ossicle deformity in a Chinese Li nationality family with spondyloepiphyseal dysplasia congenita caused by p.G504S mutation of COL2A1.
Wu K, Li Z, Zhu Y, et al.
BMC medical genomics 2021; (14(1)):170 doi:10.1186/s12920-021-01020-y.
PMID: 34182999 - 8
Novel variants in COL2A1 causing rare spondyloepiphyseal dysplasia congenita.
Zheng WB, Li LJ, Zhao DC, et al.
Molecular genetics & genomic medicine 2020; (8(3)):e1139 doi:10.1002/mgg3.1139.
PMID: 31972903 - 9
COMBINED, NOVEL MANAGEMENT OF BILATERAL VARUS HIP DEFORMITY USING "EIGHT-PLATE" IN CHILDREN WITH SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA.
Vlaić J, Ribičić T, Bojić D, Antičević D
Acta clinica Croatica 2023; (62(Suppl3)):18-24 doi:10.20471/acc.2023.62.s3.2.
PMID: 40337653 - 10
Whole-exome sequencing reveals a novel COL2A1 mutation in a patient with spondylo-epiphyseal dysplasia congenita.
Sangsin A, Srichomthong C, Pongpanich M, et al.
Genetics and molecular research : GMR 2016; (15(1)):15017624 doi:10.4238/gmr.15017624.
PMID: 26985960 - 11
Utility of Prenatal Screening and Diagnostic Testing for Skeletal Dysplasias.
Murphey N, Stevens B, Micke K, et al.
Fetal diagnosis and therapy 2025; 1-9 doi:10.1159/000548470.
PMID: 41086120 - 12
Identification of a Novel Mutation in the COL2A1 Gene in a Chinese Family with Spondyloepiphyseal Dysplasia Congenita.
Huang X, Deng X, Xu H, et al.
PloS one 2015; (10(6)):e0127529 doi:10.1371/journal.pone.0127529.
PMID: 26030151
This page explains the genetics and biology of SEDC for educational purposes only. A medical geneticist is the best source for discussing your specific genetic test results and family inheritance risks.
Get notified when new evidence is published on Spondyloepiphyseal dysplasia congenita.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.